The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review
Author(s) -
Christine S. Shusted,
Julie A. Barta,
Michael Lake,
Rickie Brawer,
Brooke Ruane,
Teresa Giamboy,
Baskaran Sundaram,
Nathaniel R. Evans,
Ronald E. Myers,
Gregory C. Kane
Publication year - 2018
Publication title -
population health management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 40
eISSN - 1942-7905
pISSN - 1942-7891
DOI - 10.1089/pop.2018.0128
Subject(s) - medicine , lung cancer , cancer , quality of life (healthcare) , colorectal cancer , excellence , medical physics , intensive care medicine , oncology , nursing , political science , law
Patient navigation has been proposed to combat cancer disparities in vulnerable populations. Vulnerable populations often have poorer cancer outcomes and lower levels of screening, adherence, and treatment. Navigation has been studied in various cancers, but few studies have assessed navigation in lung cancer. Additionally, there is a lack of consistency in metrics to assess the quality of navigation programs. The authors conducted a systematic review of published cancer screening studies to identify quality metrics used in navigation programs, as well as to recommend standardized metrics to define excellence in lung cancer navigation. The authors included 26 studies evaluating navigation metrics in breast, cervical, colorectal, prostate, and lung cancer. After reviewing the literature, the authors propose the following navigation metrics for lung cancer screening programs: (1) screening rate, (2) compliance with follow-up, (3) time to treatment initiation, (4) patient satisfaction, (5) quality of life, (6) biopsy complications, and (7) cultural competency.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom